Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C

AIM: To evaluate and compare the efficacy and safety of telaprevir (TVR)-and simeprevir (SMV)-based triple therapies in elderly patients, specifically patients aged 66 years or older. METHODS: The present study enrolled 112 and 76 Japanese patients with chronic hepatitis C virus genotype 1b infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamagiwa, Satoshi, Ishikawa, Toru, Waguri, Nobuo, Sugitani, Soichi, Wakabayashi, Hiroto, Ohkoshi, Shogo, Tsukishiro, Takashi, Takahashi, Toru, Watanabe, Toshiaki, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316845/
https://www.ncbi.nlm.nih.gov/pubmed/28261382
http://dx.doi.org/10.4254/wjh.v9.i5.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316845/
https://www.ncbi.nlm.nih.gov/pubmed/28261382
http://dx.doi.org/10.4254/wjh.v9.i5.252

Ejemplares similares